Annual report pursuant to Section 13 and 15(d)

NATURE OF OPERATIONS (Details)

v3.24.0.1
NATURE OF OPERATIONS (Details) - USD ($)
 1 Months Ended 12 Months Ended
Jan. 02, 2024
Nov. 15, 2023
May 18, 2023
Jul. 27, 2022
Jun. 29, 2021
Feb. 28, 2018
Dec. 31, 2023
Dec. 31, 2022
Warrant exercise price (in dollars per share)     $ 2.9999 $ 3.60        
Shares issued (in shares) 17,869 698,121 601,851 1,159,211 2,875,000      
Gross proceeds from stock issue   $ 2,600,000 $ 4,000,000.0 $ 4,200,000 $ 17,300,000      
Share price (in dollars per share)     $ 3.00   $ 6.00      
Pre-funded Warrant Exercise (in shares)     731,482 130,769        
Cash             $ 7,474,188 $ 9,111,751
Number of warrants     731,482 63,018        
Series A warrants                
Number of warrants       1,289,980        
Series B warrants                
Number of warrants       1,289,980        
Series C warrants                
Warrant exercise price (in dollars per share)     $ 3.26          
Number of warrants     1,333,333          
Series D warrants                
Warrant exercise price (in dollars per share)     $ 3.26          
Number of warrants     1,333,333          
At the Market Offering                
Shares issued (in shares)             698,121  
Gross proceeds from stock issue             $ 2,600,000  
Aggregate offering price   $ 17,000,000.0         $ 14,400,000  
ACX362E                
Cash paid           $ 110,174    
Future commitment           700,000    
Royalty payments           $ 50,000    
Royalty payments on net sales (as a percent)           4.00%    
ACX362E | Members' Equity, Class B                
Granting (in shares)           100,000    
Warrant exercise price (in dollars per share)           $ 0.10